Joseph Knoll, M.D., Ph.D, was an expert in the field of pharmacology and the originator of the medication Deprenyl (or Selegiline). He undertook groundbreaking research on how Deprenyl effects longevity in the 1960s, with results such as Selegiline becoming a frontline drug in the treatment of Parkinson’s Disease.
Joseph Knoll died in 2018 at the age of 93, leaving behind a long legacy of achievements.